The FTC had filed a lawsuit in May seeking to block the acquisition, arguing that the deal would “stifle competition” in the pharmaceutical industry.
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
Subscribe now to keep reading and get access to the full archive.